KAPRUKA

#CRXT New Targets @$12-14.3-20 UPTO 280%

ロング
NASDAQ:CRXT   None
Sector: Health Technology
Industry: Pharmaceuticals: Major


Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company's first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Target : USD 12-14.3-20
Resistance 2 : USD 10.15
Resistance 1 : USD 06.78

Support 1 : USD 3.37

**Disclaimer - This is not a financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
Do not view this idea as a recommendation for trading or investing. Risk Only What You Can Afford. Always Use a Stop Loss. Past performance is not necessarily a guide to future performance.

I would appreciate your feedback on my analysis.

Cheers
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。